The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of consolidation Pembrolizumab following concurrent chemoradiation in patients (pts) with unresectable or inoperable stage III non-small cell lung cancer (NSCLC): initial safety data from HCRN LUN 14-179.
 
Greg Andrew Durm
No Relationships to Disclose
 
Ebenezer A. Kio
No Relationships to Disclose
 
William B. Fisher
No Relationships to Disclose
 
Michael L. Titzer
No Relationships to Disclose
 
Salma Jabbour
No Relationships to Disclose
 
TIM Breen
No Relationships to Disclose
 
Ziyue Liu
No Relationships to Disclose
 
Nasser H. Hanna
Research Funding - Merck (Inst)